☆ 4.5 Article

Implications of IDH mutations on immunotherapeutic strategies for malignant glioma

NEUROSURGICAL FOCUS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Meeting Abstract Oncology

Final results from ClarIDHy, a global, phase III, randomized, double-blind study of ivosidenib (IVO) versus placebo (PBO) in patients (pts) with previously treated cholangiocarcinoma (CCA) and an isocitrate dehydrogenase 1 (IDH1) mutation.

Andrew X. Zhu et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

What is the burden of proof for tumor mutational burden in gliomas?

Mustafa Khasraw et al.

Summary: Pan-cancer approvals have shown benefits in treating solid tumors, but concerns arise about generalizability to other tumor types, especially in managing patients with gliomas and other CNS tumors. The undefined cutoff for TMB-H and inherent immunological differences between gliomas and other cancers are key factors to consider. Further caution should be exercised in applying recent approvals, particularly in CNS tumors.

NEURO-ONCOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

Nathan D. Mathewson et al.

Summary: This study utilized single-cell RNA sequencing to uncover the gene expression and clonal landscape of T cells in diffuse gliomas, identifying potential effectors of anti-tumor immunity. The research revealed that KLRB1 and its associated transcriptional program play an inhibitory role in tumor immunity, and blocking its function enhances T cell killing of glioma cells.

CELL (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice

Padma Kadiyala et al.

Summary: The study focuses on glioma subtypes harboring mIDH1, TP53, and ATRX inactivation. In a mouse model, inhibition of D-2HG in combination with radiation and temozolomide (IR/TMZ) led to increased survival and anti-glioma immunological memory, which was enhanced by anti-PDL1 immune checkpoint blockade resulting in complete tumor regression in 60% of mice. This combination strategy reduced T cell exhaustion and favored memory CD8(+) T cell generation.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A vaccine targeting mutant IDH1 in newly diagnosed glioma

Michael Platten et al.

Summary: Mutated isocitrate dehydrogenase 1 (IDH1) defines a molecularly distinct subtype of diffuse glioma. The most common IDH1 mutation in gliomas affects codon 132 and encodes IDH1(R132H), which harbours a shared clonal neoepitope that is presented on major histocompatibility complex (MHC) class II. An IDH1(R132H)-specific peptide vaccine (IDH1-vac) induces specific therapeutic T helper cell responses that are effective against IDH1(R132H)+ tumours.

NATURE (2021)

添加到收藏夹

Article Oncology

The immune landscape of common CNS malignancies: implications for immunotherapy

Martina Ott et al.

Summary: Immunotherapy has shown remarkable therapeutic responses in treating various cancers, with exceptions like glioblastoma. Immune profiling of samples from central nervous system tumors and brain metastases has revealed fundamental differences in immune composition, providing guidance for novel immunotherapeutic strategies.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas

Mirco Friedrich et al.

Summary: The study identifies different states of myeloid cells in gliomas and demonstrates that IDH-mutant tumors re-educate infiltrating macrophages through tryptophan metabolism, resulting in the formation of an immunosuppressive microenvironment. This suggests that targeting tryptophan metabolism could be a potential immunotherapy strategy for IDH-mutant tumors.

NATURE CANCER (2021)

添加到收藏夹

Review Oncology

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

Sue Han et al.

BRITISH JOURNAL OF CANCER (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes

Ekaterina Friebel et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells

Florian Klemm et al.

CELL (2020)

添加到收藏夹

Article Oncology

Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells

Hiroaki Nagashima et al.

CANCER DISCOVERY (2020)

添加到收藏夹

Article Oncology

IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice

Leland G. Richardson et al.

ONCOIMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

Lizza E. L. Hendriks et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

Junfei Zhao et al.

NATURE MEDICINE (2019)

添加到收藏夹

Editorial Material Oncology

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas

Leland G. Richardson et al.

TRANSLATIONAL CANCER RESEARCH (2019)

添加到收藏夹

Review Oncology

Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis

Steve Lu et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Longitudinal molecular trajectories of diffuse glioma in adults

Floris P. Barthel et al.

NATURE (2019)

添加到收藏夹

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

Lukas Bunse et al.

NATURE MEDICINE (2018)

添加到收藏夹

Article Oncology

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

Patrick Danaher et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

添加到收藏夹

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

Hussein A. Tawbi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Cell Biology

Mutant IDH1 regulates the tumor-associated immune system in gliomas

Nduka M. Amankulor et al.

GENES & DEVELOPMENT (2017)

添加到收藏夹

Article Medicine, Research & Experimental

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomase

Gary Kohanbash et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

添加到收藏夹

Article Oncology

Correlation of immune phenotype with IDH mutation in diffuse glioma

Anna Sophie Berghoff et al.

NEURO-ONCOLOGY (2017)

添加到收藏夹

Letter Medicine, General & Internal

Tumor Mutational Burden and Response Rate to PD-1 Inhibition

Mark Yarchoan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Hematology

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Eytan M. Stein et al.

BLOOD (2017)

添加到收藏夹

Article Oncology

The Microenvironmental Landscape of Brain Tumors

Daniela F. Quail et al.

CANCER CELL (2017)

添加到收藏夹

Review Clinical Neurology

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2016)

添加到收藏夹

Review Neurosciences

The role of microglia and macrophages in glioma maintenance and progression

Dolores Hambardzumyan et al.

NATURE NEUROSCIENCE (2016)

添加到收藏夹

Article Oncology

IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression

Xiaoran Zhang et al.

NEURO-ONCOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment

Hinke F. van Thuijl et al.

ACTA NEUROPATHOLOGICA (2015)

添加到收藏夹

Article Oncology

Extreme Vulnerability of IDH1 Mutant Cancers to NAD plus Depletion

Kensuke Tateishi et al.

CANCER CELL (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

Brett E. Johnson et al.

SCIENCE (2014)

添加到收藏夹

Article Medicine, General & Internal

IDH1 and IDH2 Mutations in Gliomas

Hai Yan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.